Antiverse

📍 Cardiff, United Kingdom🗓 Founded 2017👥 28 employees💰 Last funded Jan 2025
Biotechnology Research🌐 antiverse.io
Website LinkedIn
Antiverse is a Welsh techbio company specialising in antibody design for challenging drug targets, such as GPCRs and ion channels. We exist to create new enabling technologies that bring new therapies to patients to change lives. Headquartered in Cardiff, UK and with offices in Boston, MA, we combine state-of-the-art machine learning techniques and advanced cell line engineering to develop de novo antibody therapeutics.
3
Total investors
1
Early stage
1
Mid stage
1
Late stage
2017
Founded

Investors

3 investors
All
Early stage
Mid stage
Late stage
Investor geography3 countries
Czech Republic
1
United Kingdom
1
United States
1
Investor activity2019–2025 · investors recorded per year
201912021120251
Recent (last 2y)Earlier
Frequently asked questions
Who invested in Antiverse?
Antiverse has 3 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage and 1 late-stage investors.
When did Antiverse last raise funding?
The most recent investment in Antiverse recorded on gritt.io was in January 2025.
When was Antiverse founded?
Antiverse was founded in 2017.
What industry is Antiverse in?
Antiverse operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Antiverse based?
Antiverse is headquartered in Cardiff, United Kingdom.